TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

Harel Bets Big on Teva Pharmaceutical by Purchasing 4.3 Million Shares

The Motley Fool Logo The Motley Fool By Cory Renauer
Harel Bets Big on Teva Pharmaceutical by Purchasing 4.3 Million Shares

Harel Insurance Investments & Financial Services Ltd. significantly increased its stake in Teva Pharmaceutical by purchasing 4.3 million shares, valued at approximately $75.64 million, making Teva its largest holding at 6.84% of its U.S. equity assets.

Insights
MSpF   neutral

Analyst Kristine Liwag maintained a hold recommendation with a reduced price target of $45


TEVA   neutral

The company shows modest revenue growth (expected 3% year-over-year) and potential earnings improvement from branded drug sales, but has negative net income in the trailing twelve months